Sodium-dependent modulation of systemic and urinary renalase expression and activity in the rat remnant kidney

Journal of Hypertension

Volumn 31, Issue 3, 2013, Pages 543-553

  Quelhas Santos, Janete ^a   Sampaio Maia, Benedita ^a,b   Simões Silva, Liliana ^a   Serrão, Paula ^a   Fernandes Cerqueira, Cátia ^a   Soares Silva, Isabel ^a   Pestana, Manuel ^a,c  

^a University of Porto   (Portugal)

^b U Porto   (Portugal)

^c University Hospital S JoaÜo   (Portugal)

Author keywords

Rat remnant kidney; Renal dopamine; Renalase; Sodium sensitive hypertension; Sympathetic activity

Indexed keywords

CATECHOLAMINE; DOPAMINE; ENZYME; NORADRENALIN; RENALASE; UNCLASSIFIED DRUG; AMINE OXIDASE (FLAVIN CONTAINING); SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CARDIOVASCULAR RISK; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; ENZYME ACTIVITY; HEART; HEART MUSCLE CELL; HYPERTENSION; KIDNEY; KIDNEY FUNCTION; MALE; METABOLIC BALANCE; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SODIUM INTAKE; ANIMAL; BLOOD; ENZYMOLOGY; METABOLISM; URINE; WISTAR RAT;

ANIMALS; CATECHOLAMINES; DOPAMINE; KIDNEY; MALE; MONOAMINE OXIDASE; RATS; RATS, WISTAR; SODIUM;

EID: 84884194618     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32835d6e34     Document Type: Article

References (31)

1. Schiffrin EL, Lipman ML, Mann JF. Chronic kidney disease: effects on the cardiovascular system. Circulation 2007; 116:85-97. (Pubitemid 47016250)
2. Guyton AC, Coleman TG. Quantitative analysis of the pathophysiology of hypertension. 1969. J Am Soc Nephrol 1999; 10:2248-2258.
3. Koomans HA, Blankestijn PJ, Joles JA. Sympathetic hyperactivity in chronic renal failure: a wake-up call. JAmSoc Nephrol 2004; 15:524-537. (Pubitemid 38294782)
4. Pestana M, Jardim H, Serrão P, Soares-da-Silva P, Guerra L. Reduced urinary excretion of dopamine and metabolites in chronic renal parenchymal disease. Kidney Blood Press Res 1998; 21:59-65. (Pubitemid 28306443)
5. Pestana M, Jardim H, Correia F, Vieira-Coelho MA, Soares-da-Silva P. Renal dopaminergic mechanisms in renal parenchymal diseases and hypertension. Nephrol Dial Transplant 2001; 16 (Suppl 1):53-59. (Pubitemid 32492506)
6. Xu J, Li G, Wang P, Velazquez H, Yao X, Li Y, et al. Renalase is a novel, soluble monoamine oxidase that regulates cardiac function and blood pressure. J Clin Invest 2005; 115:1275-1280. (Pubitemid 40629046)
7. Hennebry SC, Eikelis N, Socratous F, Desir G, Lambert GW, Straznicky N, et al. Central and peripheral distribution of renalase, a novel soluble monoamine oxidase, in human tissue. J Hypertens 2009; 27:S33-S34.
8. Hennebry SC, Eikelis N, Socratous F, Desir G, Lambert G, Schlaich M. Renalase, a novel soluble FAD-dependent protein, is synthesized in the brain and peripheral nerves. Mol Psychiatry 2010; 15:234-236.
9. Farzaneh-Far R, Desir GV, Na B, Schiller NB, Whooley MA. A functional polymorphism in renalase (Glu37Asp) is associated with cardiac hypertrophy, dysfunction, and ischemia: data from the heart and soul study. PLoS One 2010; 5:e13496.
10. Xu J, Desir GV. Renalase, a new renal hormone: its role in health and disease. Curr Opin Nephrol Hypertens 2007; 16:373-378. (Pubitemid 46944337)
11. Desir GV. Renalase deficiency in chronic kidney disease, and its contribution to hypertension and cardiovascular disease. Curr Opin Nephrol Hypertens 2008; 17:181-185. (Pubitemid 351253044)
12. Desir GV. Renalase is a novel renal hormone that regulates cardiovascular function. J Am Soc Hypertens 2007; 1:99-103. (Pubitemid 46710832)
13. Ghosh SS, Gehr TWB, Sica DA, Masilamani S, Fakhry I, Wang R, et al. Renalase regulates blood pressure in salt sensitive Dahl rats. J Am Soc Nephrol 2006; 17:208A.
14. Wu Y, Xu J, Velazquez H, Wang P, Li G, Liu D, et al. Renalase deficiency aggravates ischemic myocardial damage. Kidney Int 2011; 79:853-860.
15. Li G, Xu J, Wang P, Velazquez H, Li Y, Wu Y, et al. Catecholamines regulate the activity, secretion, and synthesis of renalase. Circulation 2008; 117:1277-1282. (Pubitemid 351365660)
16. Luft FC. Renalase, a catecholamine-metabolizing hormone from the kidney. Cell Metab 2005; 1:358-360. (Pubitemid 43960630)
17. Desir GV. Role of renalase in the regulation of blood pressure and the renal dopamine system. Curr Opin Nephrol Hypertens 2011; 20:31-36.
18. Koomans HA, Roos JC, Boer P, Geyskes GG, Mees EJ. Salt sensitivity of blood pressure in chronic renal failure. Evidence for renal control of body fluid distribution in man. Hypertension 1982; 4:190-197. (Pubitemid 12162017)
19. Klein IH, Ligtenberg G, Neumann J, Oey PL, Koomans HA, Blankestijn PJ. Sympathetic nerve activity is inappropriately increased in chronic renal disease. J Am Soc Nephrol 2003; 14:3239-3244. (Pubitemid 37509299)
20. Vieira-Coelho MA, Hussain T, Kansra V, Serrão MP, Guimarães JT, Pestana M, et al. Aging, high salt intake, and renal dopaminergic activity in Fischer 344 rats. Hypertension 1999; 34 (4 Pt 1):666-672. (Pubitemid 29496451)
21. Vieira-Coelho MA, Serrao P, Guimaraes JT, Pestana M, Soares-da-Silva P. Concerted action of dopamine on renal and intestinal Na(+)-K(+)-ATPase in the rat remnant kidney. Am J Physiol Renal Physiol 2000; 279:F1033-F1044. (Pubitemid 32001624)
22. Institute of Laboratory Animal Research, Commission on Life Sciences, National Research Council. Guide for the care and use of laboratory animals. Washington: The National Academies Press; 1996.
23. Sampaio-Maia B, Serrão P, Guimarães JT, Vieira-Coelho MA, Pestana M. Renal dopaminergic system activity in the rat remnant kidney. Nephron Exp Nephrol 2005; 99:e46-e55.
24. Gu R, Lu W, Xie J, Bai J, Xu B. Renalase deficiency in heart failure model of rats - a potential mechanism underlying circulating norepinephrine accumulation. PLoS One 2011; 6:e14633.
25. Desir GV. Regulation of blood pressure and cardiovascular function by renalase. Kidney Int 2009; 76:366-370.
26. Zhao Q, Fan Z, He J, Chen S, Li H, Zhang P, et al. Renalase gene is a novel susceptibility gene for essential hypertension: a two-stage association study in northern Han Chinese population. J Mol Med 2007; 85:877-885. (Pubitemid 47077106)
27. Pestana M, Jardim H, Serrao P, Soares-da-Silva P, Guerra L. Reduced urinary excretion of dopamine and metabolites in chronic renal parenchymal disease. Kidney Blood Press Res 1998; 21:59-65. (Pubitemid 28306443)
28. Carey RM. Theodore cooper lecture: renal dopamine system - paracrine regulator of sodium homeostasis and blood pressure. Hypertension 2001; 38:297-302. (Pubitemid 34225655)
29. Aperia AC. Intrarenal dopamine: a key signal in the interactive regulation of sodium metabolism. Annu Rev Physiol 2000; 62:621-647. (Pubitemid 30618277)
30. Sampaio-Maia B, Moreira-Rodrigues M, Pestana M. Role of chronic inhibition of dopamine-metabolizing enzymes in the regulation of renal sodium and phosphate excretion in the rat remnant kidney. Nephron Physiol 2006; 103:14-24.
31. Desir GV, Tang L, Wang P, Li G, Sampaio-Maia B, Quelhas-Santos J, et al. Renalase lowers ambulatory blood pressure by metabolizing circulating adrenaline. J Am Heart Assoc 2012; 1:e002634.